Lee A. Albacker

<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma

Ferdinandos Skoulidis, Michael E. Goldberg, Danielle Greenawalt et al. · Cancer Discovery · 2018 · 1.6K citations · Full text

Medicine, Oncology, Pharmacology +16

Tissue expression of PD-L1 mediates peripheral T cell tolerance

Mary Keir, Spencer C. Liang, Indira Guleria et al. · The Journal of Experimental Medicine · 2006 · 1.2K citations · Full text

Life Sciences, Cell Biology, Immunology +17

Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity

Ya‐Jen Chang, Hye Young Kim, Lee A. Albacker et al. · Nature Immunology · 2011 · 759 citations

Life Sciences, Immunology, Infectious Diseases +14

Mechanisms and therapeutic implications of hypermutation in gliomas

Mehdi Touat, Yvonne Y. Li, Adam N. Boynton et al. · Nature · 2020 · 702 citations · Full text

Medicine, Molecular Genetics, Oncology +12

PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers

Mark Yarchoan, Lee A. Albacker, Alexander C. Hopkins et al. · JCI Insight · 2019 · 538 citations · Full text

Medicine, Cancer Biology, Oncology +17